Digestive System TRIZ Cases

Hydrodynamic injection delivers plasmid DNA through the biliary tree to transfect liver and pancreas cells.

Anti-CCR9 binding molecules block CCL25 interaction to prevent cell migration, achieving durable remission in inflammatory bowel disease.

A semi-solid cadotril formulation forms a crystalline structure to enhance bioavailability.

Water vapor injection stabilizes probiotic microorganisms in granules, reducing mortality below 1 log CFU/g despite thermal stress.

Lanifibranor activates all three PPAR isoforms to reprogram liver sinusoidal endothelial cells and hepatic stellate cell phenotypes.

A multi-component pharmaceutical composition enhances gastric motility and digestion through targeted herbal extracts.

A single acetate buffer system streamlines IL-13 antibody purification steps.

Antibodies with optimized variable regions boost ADCC and CDC against Claudin 18.2-expressing cancer cells.

Administering red marine macroalgae Asparagopsis to ruminants lowers methane output without compromising rumen fermentation.

A stable topical teriflunomide composition utilizes permeation enhancers to facilitate drug diffusion into the skin.

Formula I compound removes liver fat, bypassing ineffective weight loss maintenance.

Abba3 fully human immunoglobulin binds the BabA adhesin on Helicobacter pylori to prevent gastric mucosa adherence.

A Cinnamomum cassia pretreated extract composition utilizes non-polar solvent washing to remove unstable aldehydes before polar extraction.

Chicken liver hydrolysates improve alcohol metabolism and reduce collagen deposition to prevent liver fibrosis without plant extract toxicity.

COASY-specific inhibitors reduce triglyceride synthesis and plasma lipid levels to treat NAFLD.

Extraction of secretory IgA via polyethylene glycol precipitation resolves the trade-off between diverse antigen binding activity and production complexity.

A non-cyclic peptide radiotracer binds selectively to collagen type I for precise fibrosis imaging.

Air oxidation replaces toxic reagents for Linaclotide synthesis, reducing cycle time.

Multidentate shikimic acid splitters join monosaccharide ligands to nucleic acids.

Edible wax colloid forms a protective membrane on mucosal tissue, resolving side effects from long-term antacid use while restoring physiological structure.

Chardonnay grape seed flour reduces hepatic steatosis and oxidative stress in nonalcoholic fatty liver disease through proanthocyanidin activity.

Detect Methanobrevibacter smithii colonization using specific biochemical markers like HmtA and coenzyme F420 fluorescence in stool samples.

Analyzing fecal RNA markers detects sub-clinical avian necrotic enteritis without invasive tissue sampling.

Specific amino acid mutations in Kabat framework regions improve antibody expression levels without compromising antigen binding specificity or affinity.

Ferrostatin-1 targets GRIM-19 deletion-induced ferroptosis to inhibit chronic atrophic gastritis metaplasia, a precursor to gastric cancer.

Applying a purified water, alginate, corn starch polymer, and pectin banding solution prevents swelling at the capsule joint caused by gastric acid exposure.

Specific amino acid substitutions in the antibody Fc region enhance selective binding to inhibitory FcγR2B while reducing activating receptor interactions.

DMB and Antrodin A regulate gene expression to repair damaged hepatic cells despite irreversible hepatocyte death.

Mastic resin and essential oil formulations reduce Porphyromonas bacterial loads in pets, eliminating the need for difficult tooth brushing routines.

RNA interference reduces hepatic GPR110 expression, resolving the trade-off between treatment effectiveness and side effects on other organs.

Identifying SMYD2 amplification enables precise early diagnosis while siRNA agents suppress cell growth to improve prognosis.

ELISA and lateral flow kits use monoclonal antibodies to measure CD5L levels accurately.

Tirilazad salts inhibit protease enzymes and oxidative radicals, resolving laminitis treatment gaps without complex protocols.

Decolorized aloe vera extracts increase transepithelial electrical resistance and reduce permeability to repair injured intestinal barriers.

Modified adenosine derivatives inhibit steatosis and inflammation by targeting A3 receptors, resolving selectivity issues in liver disease treatment.

A whole blood gene expression signature enables direct IBD progression risk assessment without cell isolation.

Anti-progastrin antibodies bind progastrin to destroy cancer cells while sparing healthy tissue from chemotherapy side effects.

Macrocyclic compounds inhibit the hepatitis C virus NS3 protease, addressing limited clinical benefits of existing interferon therapies.

Filtration removes live pathogens from stool preparations, resolving safety risks while maintaining therapeutic efficacy.

Tripeptide compounds inhibit the hepatitis C virus NS3 protease through optimized amino acid side chains and segmented molecular structures.

SNP genotyping determines specific genetic markers to predict clinical outcomes and guide therapy selection for gastroesophageal cancer patients.

Topical Cromolyn sodium prevents Oral Allergy Syndrome symptoms by stabilizing mast cells before allergen exposure.

Functionalised chitosan modulates galectin-3 to resolve viral-induced inflammation and fibrosis while minimizing side effects from conventional treatments.

Benzofuran compounds with boron moieties inhibit hepatitis C virus replication through targeted molecular interactions.

Polykinase inhibitor nanoparticles prime the tumor microenvironment, resolving unpredictable efficacy of anti-PD-1 antibodies.

Mixed suspending agents maintain aluminum hydroxide dispersion, preventing sedimentation and bioavailability loss.

Periodic anti-IL-23A antibody administration intervals reduce corticosteroid reliance while sustaining deep endoscopic remission.